Bone repair involves bone resorption through osteoclastogenesis and the stimulation of neovascularization and osteogenesis by endothelial progenitor cells (EPCs).
| INTRODUC TI ON
The process of bone healing occurs appropriately in the majority of cases through the formation of callus.
1 However, some fractures fail to heal which can result in delayed union or persistent non-union and prolonged disability. 2 There are various causes of failed bone repair including inadequate blood supply, inappropriate angiogenesis, insufficient immobilization and infection. [3] [4] [5] In particular, the initiation of bone repair involves appropriate bone resorption through osteoclastogenesis. 6, 7 Osteoclasts originate from the precursors of macrophage/monocyte lineage and are cells that specialize in bone resorption. 8 The osteoclast is responsible for removing the organic and inorganic components of bone and is critical for normal bone function. 9 Osteoclastogenesis is induced by the expression of numerous genes, including MMP9, CTSK, TRAP and CAR2. 10 Endothelial progenitor cells (EPCs) are believed to promote bone repair by stimulating neovascularization and osteogenesis. [10] [11] [12] In the absence of appropriate vascularization, hypoxia and the disruption of biomechanical signalling pathways can prevent the regeneration of bone tissue. 6 Moreover, the process of bone formation is thought to be coupled to the process of angiogenesis. 7, 8 Pro-angiogenic factors secreted by bone cells, such as VEGF, can trigger signalling responses from various cells expressing VEGF receptors, which include endothelial cells and osteoclasts. 9 EPCs contribute to the formation of new blood vessels and indirectly contribute to the formation of new bone during bone repair. 13 It has been proposed that endothelial cell-specific and cell-autonomous Notch activity regulates bone angiogenesis and couples it to osteogenesis, possibly by interactions with VEGF.
14 Non-coding RNAs are generally allocated into two major classes based on size, with those over 200 nucleotides referred to as long non-coding RNAs (lncRNAs) and the others called microRNAs (miRNAs). 15 Non-coding RNA possess no apparent protein-coding capability but participate in various biological and pathological processes and a number have been implicated in osteogenesis. [16] [17] [18] In previous research, microRNA-124 (miR-124) was found to regulate osteoclast differentiation of mouse bone marrow-derived macrophages (BMMs) by suppressing nuclear factor of activated T cell, cytoplasmic 1 (NFATc1) expression.
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miR-124 was also found to negatively regulate osteogenic differentiation and bone formation in mesenchymal stem cells by interacting with Dlx transcription factors, which play an important role in osteoblast differentiation. 20 Several studies have implicated that lncRNAs dysregulate miRNAs through competitive binding. 21, 22 Lnc-MALAT1 is thought to competitively regulate miR-124 to promote EMT and the development of non-small cell lung cancer. 23 Therefore, lncRNA MALAT-1 may influence the role of miR-124 in osteogenesis. Integrin subunit β 1 (ITGB1) is thought to be the target of miR-124. Interestingly, ITGB1 was found to be the major and essential β integrin receptor for insulin-like growth factor-binding protein 1 (IGFBP1) and is thought to be responsible for its pro-osteoclastogenic function.
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In a preliminary study, we found that EPCs enhance the migration and osteoclastic differentiation of BMMs in vitro and in a mouse femur fracture model. However, the role of EPCs in osteoclast formation and function is still unclear. EPC-derived exosomes have been found to participate in the communication between EPCs and bone marrow stromal cells to promote osteoblastic differentiation by inhibiting the expression of osteogenic genes and increasing proliferation in vitro. 25 In this study, we examined the effects of EPCderived exosomes on the migration and osteoclastic differentiation of primary mouse BMMs in vitro. We also evaluated the effects of EPC-derived exosomes on the homing and osteoclastic differentiation of transplanted BMMs in a mouse bone fracture model in vivo.
In summary, the aim of this study was to test the hypothesis that EPC-derived exosomes may promote osteoclastogenesis through the Lnc-MALAT-1/miR-124 pathway.
| MATERIAL S AND ME THODS

| Animals
Sixty C57BL/10 mice (6 weeks old) were obtained from the Model 
| Isolation of EPCs and BMMs
To isolate EPCs, cells expressing the early EPC surface marker CD133
were selected from mouse umbilical cord blood using anti-CD133-coupled magnetic microbeads (Miltenyi Biotech, Bergisch Gladbach, Germany). The EPCs were then cultured in DMEM supplemented with 10% foetal bovine serum (FBS). Monoclonal antibodies against CD31, CD34, CD133, vWF and UFA-1 (Sigma-Aldrich, St. Louis, MO)
were used to conduct immunophenotypic analysis on the EPCs with Isotype-identical antibodies as controls (PharMingen, San Diego, CA).
The carbocyanine fluorescent dye Dil (Molecular Probes, Eugene, OR) was used to counterstain cells. The angiogenic capacity of early EPCs was determined by a Matrigel tube formation assay as described in our previous report. 26 In brief, Matrigel (Sigma-Aldrich) was diluted in 500 μl EGM-2 media (1:1 v/v) in 96-well plates and incubated at 37°C for 1 hour to allow polymerization. EPCs (2 × 10 4 cells/well) were seeded onto the Matrigel and incubated at 37°C for 24 hours. Digital micrographs were taken for morphological analysis.
| BMMs isolated from mouse calvariae
Primary BMMs were isolated from the whole bone marrow. Briefly, 6-week-old C57BL/10 mice were killed by rapid decapitation under deep anaesthesia with 10% chloral hydrate, marrow was extracted from femora and tibiae and placed in Petri dishes in a culture medium composed of α-minimal essential medium (α-MEM) supplemented with 10% inactivated FBS, 100 IU/mL penicillin G and 100 μg/mL streptomycin and CMG medium (conditioned medium containing 100 ng/mL mouse M-CSF) in a 1:10 ratio. Cells were incubated at 37°C with 5% CO 2 for 3 days. When the medium was changed, the cells were washed to deplete residual stromal cells. 
| Isolation and identification of EPC-exosomes
Medium collected from EPCs was centrifuged to remove cellular debris (2500 × g for 15 minutes at 4°C) and filtered with a 0. 
| Transwell migration assay
Bone marrow-derived macrophages (1 × 10 5 /well) were loaded into the upper chamber in MEM-α media with 5% FBS and EPCs into the lower chamber of Transwell inserts with a pore size of 8 μm (Costar, NY). After incubation (37°C with 5% CO 2 for 5 days), the BMMs were rinsed with PBS, fixed in 10% formalin for 10 minutes and stained with DAPI for 15 minutes. The migration capacity of the BMMs was determined under an inverted light microscope as described previously. 27 Cells that had migrated to the lower surface of the membrane were counted in three randomly selected fields.
| Cell transfection
For Lnc-MALAT1 expression analysis, siRNA against the Lnc- 
| Luciferase reporter assay
HEK293T cells were cotransfected with plasmids containing 3′-UTR of wild or mutant fragments from ITGB1 or predicted binding sequence from Lnc-MALAT1 and miRNA mimics using Lipofectamine 2000 (Invitrogen) according to the manufacturer's protocol. Fortyeight hours after transfection, firefly and Renilla luciferase activities were measured consecutively by using a dual-luciferase reporter assay system (Promega, Fitchburg, WI). Ratios of luminescence from firefly to Renilla luciferase were calculated and each assay was repeated in three independent experiments.
| Quantitative real-time PCR analysis
RNA was isolated from BMMs or bone tissues using TRIzol (Invitrogen). cDNA was synthesized from 1 μg of total RNA in 21-μl reaction volumes using oligo dT18 primers and SuperScript reverse transcriptase. PCR amplification was carried out with Taq DNA polymerase (TaKaRa, Tokyo, Japan) using 1 μl of the first-strand cDNAs as templates. The amplification reactions were run with 30 thermocycles of 30 seconds at 94°C, 30 seconds at 55°C and 30 seconds at 72°C.
| Ribonucleoprotein immunoprecipitation (RIP) assay
Anti-AGO2 ribonucleoprotein immunoprecipitation (RIP) was per- 
| RNA interference
Bone marrow-derived macrophages were collected and resus- 
| Western blot analysis
Proteins (50 μg) from lysed cells were separated by 10% SDS-PAGE and transferred to nitrocellulose membranes. After blocking for 2 hours, the membranes were incubated overnight with primary antibodies followed by horseradish peroxidase (HRP)-conjugated secondary antibodies. The protein bands were visualized using enhanced chemiluminescence. Densitometry analysis of protein levels was performed with Gel-pro Image Analysis Software (Media Cybernetics, Rockville, MD, USA).
| Femur fracture model
The 
| Microcomputed tomography
The trabecular volumes at the distal femoral metaphysis and proximal tibia were determined using a Scanco CT40 scanner (Scanco Medical AG, Bassersdorf, Switzerland). Approximately, 100 slices were analysed, beginning at the point where the condyles and primary spongiosa were no longer visible.
| Statistical analysis
All data are reported as the mean ± SD. The Student's two-tailed unpaired t test was used to determine differences between two groups. A P < 0.05 was regarded as statistically significant.
| RE SULTS
| EPCs promote the migration and osteoclastic differentiation of BMMs through exosomes
The influence of EPCs on the migration and osteoclastic differentia- whereas levels of miR-124 were increased (P < 0.001 vs co-culture).
Similar results were observed in protein levels of ITGB1 by western blot analysis ( Figure 1G ).
The concentration of exosomes in the solution was about 1.35 × 10 9 /mL and identified in EPCs by TEM (Figure 2A ). Western blotting using the positive exosomal markers CD63 and CD81
( Figure 2B ) and negative exosome markers GM130 and calnexin ( Figure 2C ) were also used to identify exosomes. Levels of lncRNA-MALAT1 mRNA were found to be significantly higher in EPC-derived exosomes than in EPCs ( Figure 2D ) and lncRNA-MALAT1 expression was inhibited in EPC-derived exosomes transfected with a lncRNA-MALAT1-targeting siRNA ( Figure 2E ).
Overall, these results indicate that exosomes released from EPCs give rise to increased levels of migration and osteoclastic differentiation in BMMs. Moreover, EPC-derived exosomes increased the levels of lncRNA-MALAT1 and ITGB1 in BMMs but decrease the levels of miR-124.
| MALAT-1 competitively regulated miR-124
A putative binding site for miR-124 was mutated in lncRNA-MALAT1
and the binding of lncRNA-MALAT1 to miR-124 was confirmed in HEK-293T cells by assessing luciferase activity ( Figure 3A,B) . in Exo-siMALAT1-treated BMMs were reduced compared to ExosiNC-treated BMMs, however the expression of miR-124 was elevated ( Figure 4E ). There were also higher levels of ITGB1 protein in BMMs treated with Exo-siNC compared to Exo-siMALAT1 with almost undetectable levels of ITGB1 in untreated BMMs ( Figure 4F ).
These results indicate that an interaction exists between miR-124 and lncRNA-MALAT1, which has consequences on the migration and osteoclastic differentiation of BMMs.
| Exosomes induced osteoclastic differentiation through inhibition of miR-124
We next assessed whether a potential miR-124 binding site on the 3′-UTR of ITGB may influence migration of osteoclastic differentiation.
The potential 3′-UTR binding site was mutated and an interaction between miR-124 and ITGB1 was confirmed through a luciferase reporter assay in HEK-293T cells ( Figure 5A,B) . Figure 7C) . Moreover, the density of Dil-positive capillaries at the fracture site at week 4 was significantly greater in Exo-siNC-treated mice (P < 0.001 vs control, P < 0.01
vs Exo-siMALAT1-treated mice) ( Figure 7D ). The mRNA levels of lncRNA-MALAT1, miR-124 and ITGB1 were evaluated in BMMs either grown alone or treated with Exo-siNC or Exo-siMALAT1.
RT-PCR results showed that the expression of lncRNA-MALAT1
and ITGB1 was elevated in BMMs treated with Exo-siNC compared with BMMs treated with Exo-siMALAT1 or the control.
However, levels of miR-124 decreased ( Figure 7E ). ITGB1 protein levels were also increased in Exo-siNC-treated mice ( Figure 7F ).
Representative fluorescence images of TRAP staining in Dil-la- Several studies have suggested that lncRNAs can base pair with miRNAs, thereby, effectively depleting them by acting as a sponge or decoy. [29] [30] [31] For instance, a recent study found that microRNA-487b
was a direct target of lncRNA muscle anabolic regulator 1 (MAR1).
32
LncRNA MAR1 acts as a miR-487b sponge to regulate the Wnt5a protein, which results in the promotion of muscle differentiation and regeneration. Moreover, other studies have also found that these LncRNA are enriched in exosomes 33, 34 and may even provide new diagnostic and prognostic markers in a tumour environment.
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In the present study, we found that EPC-derived exosomes increase the mRNA expression of MMP9, CTSK, TRAP and CAR2, genes associated with osteoclastic differentiation, whereas overexpressing miR-124 or silencing lncRNA-MALAT1 decreased the expression of these genes. It has been suggested that osteoclasts stimulate angiogenesis by the secretion of MMP-9. 36 MMP-9 is thought to be important in osteoclast invasion of the long bone growth plate and VEGF-induced osteoclast migration. 37 CTSK, used as a marker of osteogenesis in this study, is a cysteine protease that is secreted by osteoclasts to degrade matrix collagen. 38 More importantly, CTSK activates TRAP, which is highly expressed in osteoclasts where it initiates the dephosphorylation of bone matrix phosphoproteins. 39 The use of TRAP as a molecular marker has allowed the identification of several miRNAs involved in osteoclastogenesis processes, including miR-124. 40 Previous studies have indicated that miR-124 may negatively regulate osteoclast differentiation by suppressing the expression of NFATc1, a key regulator of osteoclastogenesis. 19, 41 In agreement with our results, the expression of miR-124 was found to decrease during osteoclastic differentiation, moreover, inhibition of miR-124 was found to promote NFATc1 expression and osteoclastogenesis.
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In this study, we also discovered that there was a potential ling. 42 The failed activation of β1 integrins is associated with osteoclast dysfunction.
43
Bone defects are normally treated with autologous bone grafting. However, this approach has limitations due to the problems associated with retrieving bone tissue from a second site.
Bioactive scaffolds are being adopted as an alternative solution to allow the attachment and differentiation of transplanted cells. 44 In this study, we have exploited the exosomal location of ) mRNA levels of MMP9, CTSK, TRAP and CAR2; J, western blot analysis of MMP9, CTSK, TRAP and CAR2 in tissues at the fracture site at day 7. n = 3; *P < 0.05, **P < 0.01, ***P < 0.001 vs control; # P < 0.01, ## P < 0.01, ### P < 0.001 vs Exo-siMALAT1
to negatively control miR-124 activity. This, in turn, may regulate levels of integrins, such as ITGB1, which play an important role in osteoclastogenesis through substrate recognition, cytoskeletal organization and matrix-derived signalling. We also demonstrated that EPC-derived exosomes expressing LncRNA-MALAT1 could be delivered successfully to a bone fracture site in an animal model to increase neovascularization. Overall, our results suggest that EPCderived exosomes can promote bone repair in vivo by enhancing recruitment and differentiation of osteoclast precursors through controlling levels of miR-124 via LncRNA-MALAT1.
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